| Mr Marc Brandell, RPH | |
|
21333 39th Ave Ste 236, Bayside, NY 11361-2092 | |
| (716) 932-2650 | |
| (716) 932-2651 |
| Full Name | Mr Marc Brandell |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 21333 39th Ave Ste 236, Bayside, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164753257 | NPI | - | NPPES |
| 37735 | Other | NY | PHARMACY LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 37735 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Marc Brandell, RPH 21333 39th Ave Ste 236, Bayside, NY 11361-2092 Ph: (716) 932-2650 | Mr Marc Brandell, RPH 21333 39th Ave Ste 236, Bayside, NY 11361-2092 Ph: (716) 932-2650 |
News Archive
Researchers have discovered that a particular protein can be used as a brain marker to indicate whether emotional memories can be changed or forgotten.
Forest Laboratories, Inc. and Cypress Bioscience, Inc. have announced that Savella (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food and Drug Administration (FDA) for the management of fibromyalgia.
Roche has announced that it has submitted a combined filing to the European health authorities (the European Medicines Agency) for three new indications to extend the label for MabThera to use as a first-line biologic therapy for patients with rheumatoid arthritis (RA).
Research by several leading scientists including Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported in part by the National Foundation for Cancer Research, has provided the first evidence that the century-old model for cancer metastasis - where cancer spreads from primary tumor to nearby lymph nodes, and then to other organs - may not apply in all cases.
The U.S. Preventive Services Task Force recommendation against regular prostate specific antigen (PSA) screening for prostate cancer (PCa) has been in place for two and a half years. Although the number of prostate needle biopsies (PNB) has been reduced, patients who undergo PNB are significantly more likely to be diagnosed with high risk disease, and detection of intermediate risk, potentially curable PCa has likely decreased.
› Verified 2 days ago
Ok Chung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21012 39th Ave, 3 Floor, Bayside, NY 11361 Phone: 718-225-2999 | |
Anora Nuritdinova, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21220 Northern Blvd, Bayside, NY 11361 Phone: 718-281-3223 | |
Dimitrios Dakis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 35-15 Francis Lewis Blvd, Bayside, NY 11358 Phone: 718-539-7752 | |
Ms. Marian Habib, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3920 Bell Blvd, Bayside, NY 11361 Phone: 718-224-2606 | |
Mei Qing Liu, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21508 73rd Ave, Bayside, NY 11364 Phone: 718-479-2782 | |
William Choi, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21970 64th Ave #c, Bayside, NY 11364 Phone: 917-386-7483 | |
Maria Isabella Bruno, DOCTOR OF PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 21220 Northern Blvd, Bayside, NY 11361 Phone: 718-281-3223 |